AUSTIN, Texas, Aug. 02, 2017 (GLOBE NEWSWIRE) -- Medical Marijuana, Inc. (OTC Pink:MJNA) (the Company) and SmallCapVoice.com, Inc. (SCV) announced today that a new audio interview with Medical Marijuana, Inc., the first-ever publicly traded cannabis company in the United States, is now available. The interview can be heard at http://smallcapvoice.com/blog/7-28-17-smallcapvoice-interview-with-medical-marijuana-inc-mjna.
Medical Marijuana, Inc. CEO Dr. Stuart Titus called in to SmallCapVoice.com to provide the listening audience with his insights into the drivers behind the Company's largest-ever single month of revenue in June 2017 as well as the largest sales month and quarter for wholly owned subsidiary Kannaway. Dr. Titus also provided updates on several of MJNA's subsidiaries and its major investment AXIM Biotechnologies, Inc. (OTC:AXIM).
In the interview Dr. Titus stated, “Kannaway has been performing fabulously well throughout the year. They are certainly a big part of our growth in terms of sales. AXIM Biotechnologies (OTC:AXIM), we believe has always held a tremendous amount of promise being one of the premier up and coming biotechnologies companies particularly in the cannabinoid space. We are certainly excited about some of the recent developments with AXIM.”
About SmallCapVoice.com
SmallCapVoice.com is a recognized corporate investor relations firm, with clients nationwide, known for its ability to help emerging growth companies build a following among retail and institutional investors. SmallCapVoice.com utilizes its stock newsletter to feature its daily stock picks, audio interviews, as well as its clients' financial news releases. SmallCapVoice.com also offers individual investors all the tools they need to make informed decisions about the stocks they are interested in. Tools like stock charts, stock alerts, and Company Information Sheets can assist with investing in stocks that are traded on the OTC BB and Pink Sheets. To learn more about SmallCapVoice.com and their services, please visit http://smallcapvoice.com/blog/the-small-cap-daily-small-cap-newsletter/
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
About Medical Marijuana, Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.'s portfolio and investment companies, visit www.medicalmarijuanainc.com.
To see Medical Marijuana, Inc.'s video statement, click here. Shareholders are also encouraged to visit the Medical Marijuana, Inc. Shop for discounted products.
FORWARD-LOOKING DISCLAIMER AND DISCLOSURES
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties. The statements in this press release have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease. The Company does not sell or distribute any products that are in violation of the United States Controlled Substances Act. The Company does sell and distribute hemp-based products.